These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 22455733)
1. C60 fullerene derivatized nanoparticles and their application to therapeutics. Lin CM; Lu TY Recent Pat Nanotechnol; 2012 Jun; 6(2):105-13. PubMed ID: 22455733 [TBL] [Abstract][Full Text] [Related]
2. C60-fullerenes as Drug Delivery Carriers for Anticancer Agents: Promises and Hurdles. Kumar M; Raza K Pharm Nanotechnol; 2017; 5(3):169-179. PubMed ID: 29361902 [TBL] [Abstract][Full Text] [Related]
3. Carbon nanomaterials: Biologically active fullerene derivatives. Bogdanović G; Djordjević A Srp Arh Celok Lek; 2016; 144(3-4):222-31. PubMed ID: 27483572 [TBL] [Abstract][Full Text] [Related]
4. [Preparation and Evaluation of Fullerene Based Nanomedicine]. Iohara D Yakugaku Zasshi; 2019; 139(12):1539-1546. PubMed ID: 31787641 [TBL] [Abstract][Full Text] [Related]
5. [Development of Bio-active Fullerene Derivatives Suitable for Drug]. Mashino T Yakugaku Zasshi; 2022; 142(2):165-179. PubMed ID: 35110453 [TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of neurodegenerative disorders employing nanoparticles. Spuch C; Saida O; Navarro C Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933 [TBL] [Abstract][Full Text] [Related]
8. Water-Soluble Fullerene Derivatives as Brain Medicine: Surface Chemistry Determines If They Are Neuroprotective and Antitumor. Hsieh FY; Zhilenkov AV; Voronov II; Khakina EA; Mischenko DV; Troshin PA; Hsu SH ACS Appl Mater Interfaces; 2017 Apr; 9(13):11482-11492. PubMed ID: 28263053 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know? Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance. Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268 [TBL] [Abstract][Full Text] [Related]
11. Medicinal applications of fullerenes. Bakry R; Vallant RM; Najam-ul-Haq M; Rainer M; Szabo Z; Huck CW; Bonn GK Int J Nanomedicine; 2007; 2(4):639-49. PubMed ID: 18203430 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of fullerene (C60) amino acid nanoparticles for liver cancer cell treatment. Li Z; Pan LL; Zhang FL; Wang Z; Shen YY; Zhang ZZ J Nanosci Nanotechnol; 2014 Jun; 14(6):4513-8. PubMed ID: 24738422 [TBL] [Abstract][Full Text] [Related]
13. Nano-interventions for neurodegenerative disorders. Fernandes C; Soni U; Patravale V Pharmacol Res; 2010 Aug; 62(2):166-78. PubMed ID: 20153429 [TBL] [Abstract][Full Text] [Related]
14. Recent progress of drug nanoformulations targeting to brain. Khan AR; Yang X; Fu M; Zhai G J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256 [TBL] [Abstract][Full Text] [Related]
15. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review. Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421 [TBL] [Abstract][Full Text] [Related]
16. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620 [TBL] [Abstract][Full Text] [Related]
17. Fullerenes for applications in biology and medicine. Anilkumar P; Lu F; Cao L; Luo PG; Liu JH; Sahu S; Tackett KN; Wang Y; Sun YP Curr Med Chem; 2011; 18(14):2045-59. PubMed ID: 21517770 [TBL] [Abstract][Full Text] [Related]
18. Fullerene derivatives: an attractive tool for biological applications. Bosi S; Da Ros T; Spalluto G; Prato M Eur J Med Chem; 2003; 38(11-12):913-23. PubMed ID: 14642323 [TBL] [Abstract][Full Text] [Related]
19. Antitumor Activity and Potential Mechanism of Novel Fullerene Derivative Nanoparticles. Ye L; Kollie L; Liu X; Guo W; Ying X; Zhu J; Yang S; Yu M Molecules; 2021 May; 26(11):. PubMed ID: 34071369 [TBL] [Abstract][Full Text] [Related]
20. Micro- and nanoparticles--medical applications. Jătariu A; Peptu C; Popa M; Indrei A Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]